| Company Name: |
cjbscvictory
|
| Tel: |
13348960310 |
| Email: |
3003867561@qq.com |
| Products Intro: |
Product Name:Iferanserin
CAS:58754-46-4
Purity:98% Package:5mg；10mg；20mg；50mg；100mg；200mg
|
| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
4008200310 |
| Email: |
marketing@tsbiochem.com |
| Products Intro: |
Product Name:Iferanserin
CAS:58754-46-4
Package:2mg/RMB 2890;25mg/RMB 10600;50mg/RMB 13800
|
(E)-N-[2-[2-[(2S)-1-methyl-2-piperidyl]ethyl]phenyl]-3-phenyl-prop-2-e namide manufacturers
- Iferanserin
-
- $1400.00 / 25mg
-
2025-10-27
- CAS:58754-46-4
- Min. Order:
- Purity:
- Supply Ability: 10g
|
| | (E)-N-[2-[2-[(2S)-1-methyl-2-piperidyl]ethyl]phenyl]-3-phenyl-prop-2-e namide Basic information |
| | (E)-N-[2-[2-[(2S)-1-methyl-2-piperidyl]ethyl]phenyl]-3-phenyl-prop-2-e namide Chemical Properties |
| storage temp. | 4°C, away from moisture and light | | form | Solid | | color | White to off-white |
| | (E)-N-[2-[2-[(2S)-1-methyl-2-piperidyl]ethyl]phenyl]-3-phenyl-prop-2-e namide Usage And Synthesis |
| Uses | Iferanserin (S-MPEC) is a selective 5-HT receptor (serotonin receptor) antagonist with an affinity for 5-HT2A receptor. Iferanserin has the potential for internal hemorrhoid disease treatment[1]. | | IC 50 | 5-HT2A Receptor | | References | [1] Herold A, et al. Intra-anal Iferanserin 10 mg BID for hemorrhoid disease: a prospective, randomized, double-blind, placebo-controlled trial. Clin Ther. 2012 Feb;34(2):329-40. DOI:10.1016/j.clinthera.2011.12.012 |
| | (E)-N-[2-[2-[(2S)-1-methyl-2-piperidyl]ethyl]phenyl]-3-phenyl-prop-2-e namide Preparation Products And Raw materials |
|